New treatment option for Supracondylar Humerus Fracture
Official title Supracondylar Post-Operative Pain Study
ClinicalTrials.gov ID: NCT03759028
What this study is testing
What is Ibuprofen?
Ibuprofen is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for supracondylar humerus fracture.
Also referred to as Advil, Motrin.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The purpose of this study to investigate post-operative pain control in pediatric patients with closed supracondylar humerus fracture who undergo closed reduction and percutaneous pinning. Currently, it is standard of care that patients receive a narcotic prescription for post-operative pain control.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 4 to 12
You may be able to join if
- Closed supracondylar humerus fracture
- Isolated supracondylar humerus fracture
- Type II and III supracondylar humerus fracture
- Fractures treated with closed reduction percutaneous pinning
You likely can't join if
- Fractures with concomitant vascular injury
- Fractures with concomitant neurologic deficit
- Pathologic fractures
- Fractures with concomitant injuries (multiple trauma)
- Fractures with swelling requiring post-operative hospitalization for monitoring
- Known history of allergies to acetaminophen, ibuprofen or oxycodone
See the full eligibility criteria
- Closed supracondylar humerus fracture
- Isolated supracondylar humerus fracture
- Type II and III supracondylar humerus fracture
- Fractures treated with closed reduction percutaneous pinning
- Fractures with concomitant vascular injury
- Fractures with concomitant neurologic deficit
- Pathologic fractures
- Fractures with concomitant injuries (multiple trauma)
- Fractures with swelling requiring post-operative hospitalization for monitoring
- Known history of allergies to acetaminophen, ibuprofen or oxycodone
- Patients with developmental delay that would preclude participation in the visual analog Faces Pain Scale-Revised
- Patients with intellectual disability that would preclude participation in the visual analog Faces Pain Scale-Revised
- History of suspected child abuse
The study team makes the final eligibility decision.
Where it's taking place
- Los Angeles, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 4 years to 12 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Los Angeles, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.